EULAR® 2024 Insights

 

Systemic and Connective Tissue Disease
12:45

EULAR® 2024 Insights

EULAR ® Insights - The Most Reliable Tools and Methods and Their Combinations for the Evaluation of the Microcirculation in Systemic Sclerosis

FEATURING Ariane Herrick
  • 2 views
  • June 21, 2024
10:57

EULAR® 2024 Insights

EULAR® 2024 Insights: The Effects of Immunosupressive Therapy on Glandular Involvement in Patients with Primary Sjögren’s Syndrome

FEATURING Guzide Inanc
  • 9 views
  • June 21, 2024
05:34

EULAR® 2024 Insights

EULAR® 2024 Insights - Predictive Significance of Biomarkers in Systemic Sclerosis-Associated Interstitial Lung Disease: Insights into Progression, Lung Volume Changes, and Mortality Risk

FEATURING Cristiana Sieiro Santos
  • 89 views
  • June 21, 2024
12:52

EULAR® 2024 Insights

EULAR ® Insights: The Most Reliable Tools and Methods and Their Combinations for the Evaluation of the Microcirculation in Systemic Sclerosis

FEATURING Ariane Herrick
  • 6 views
  • June 21, 2024
19:48

EULAR® 2024 Insights

EULAR® 2024 Insights - Decoding the Immunopathophysiology of Polymyalgia Rheumatica: Unraveling the Mysteries Within

FEATURING Ernest Choy
  • 88 views
  • June 19, 2024
04:43

EULAR® 2024 Insights

EULAR® 2024 Insights: Characteristics Associated with Long-Term Glucocorticoids Use in Patients with New Onset Polymyalgia Rheumatica

FEATURING Andrea Rubbert-Roth
  • 89 views
  • June 19, 2024